Targeted Medical Pharma, Inc. (OTCMKTS:TRGM – Get Free Report)’s stock price passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Targeted Medical Pharma shares last traded at $0.00, with a volume of 0 shares traded.
Targeted Medical Pharma Trading Down 100.0 %
Targeted Medical Pharma Company Profile
Targeted Medical Pharma, Inc, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy.
Featured Articles
- Five stocks we like better than Targeted Medical Pharma
- 3 REITs to Buy and Hold for the Long Term
- 3 Must-Hold Stocks with Double-Digit Upside for 2025
- Investing in Commodities: What Are They? How to Invest in Them
- Micron: Why Now Is the Time to Be Brave
- How to buy stock: A step-by-step guide for beginnersÂ
- 3 Stocks That Wall Street Insiders Can’t Stop Buying
Receive News & Ratings for Targeted Medical Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Targeted Medical Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
